Coherus BioSciences Inc (NAS:CHRS)
$ 1.88 -0.03 (-1.57%) Market Cap: 215.68 Mil Enterprise Value: 440.51 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q4 2021 Coherus BioSciences Inc Earnings Call Transcript

Feb 17, 2022 / 10:00PM GMT
Release Date Price: $12.85 (-2.50%)
Operator

Good day, and thank you for standing by. Welcome to the Fourth Quarter and Full Year 2021 Coherus BioSciences Earnings Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded. (Operator Instructions)

I would now like to hand the conference over to your host today McDavid Stilwell, Chief Financial Officer. Please go ahead, sir.

McDavid Stilwell
Coherus BioSciences, Inc. - CFO

Thank you operator. Good afternoon everyone and thank you for joining us. We issued our press release earlier announcing our 2021 fourth quarter and full year results. This release can be found on the Coherus BioSciences' website. Today's call includes forward-looking statements regarding Coherus' current expectations about future events. These statements include, but are not limited to, our ability to advance our product candidates through development and registration, the status of our product candidate clinical profile, our timing and ability to commercialize our products and product candidates in the future. Our R&D and SG&A

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot